MOGAD
6 all articles · 20 / page
Latest news
Tag

Interleukin 6 Receptor Blockade: A Promising Strategy for Relapse Prevention in MOG Antibody-Associated Disease
IL-6 receptor blockade significantly reduces relapse rates in MOG antibody-associated disease, showing comparable efficacy to high-dose IVIG with a favorable safety profile, supporting its role in relapse prevention.

Disability Dynamics Independent of Attacks in AQP4-IgG+ NMOSD and MOGAD: Insights from a Multicenter Cohort Study
This study reveals that disability improvement and worsening independent of attacks, though rare, occur in AQP4-IgG+ NMOSD and MOGAD. Early attack prevention and younger age are key factors influencing disability trajectories.



